{"url_path":"/sec/tak/10-k/2026/item-16c","section_key":"item-16c","section_title":"Item 16C Principal Accountant Fees and Services","topic":"sec","document":{"doc_type":"20-F","doc_date":"2026-06-17","source_url":"https://www.sec.gov/Archives/edgar/data/1395064/0001395064-26-000177-index.html","accession_number":"0001395064-26-000177","cik":"0001395064","ticker":"TAK","issuer_name":"TAKEDA PHARMACEUTICAL CO LTD","edgar_url":"https://www.sec.gov/Archives/edgar/data/1395064/0001395064-26-000177-index.html","primary_entity_key":"0001395064","primary_entity_name":"TAKEDA PHARMACEUTICAL CO LTD"},"word_count":483,"has_tables":true,"body_markdown":"Item 16C. Principal Accountant Fees and Services\n\nAudit and Non‑Audit Fees\n\nThe following table sets forth the fees billed to us by our independent certified public accountant, KPMG AZSA LLC (including its Japanese and non-Japanese affiliates), in the fiscal years ended March 31, 2025 and 2026:\n\nFor the fiscal year ended\nMarch 31,\n\n20252026\n\n(billions of yen)\n\nAudit fees*1\n¥3.57 ¥3.15 \n\nAudit‑related fees*2\n0.14 0.21 \n\nTax fees *3\n— 0.00 \n\nOther fees*4\n0.07 — \n\nTotal fees\n¥3.78 ¥3.36 \n\n*1Audit fees were related to the audit of our consolidated financial statements and other audit services provided in connection with statutory and regulatory filings or engagements.\n\n*2Audit‑related fees include fees related to other assurance and related services, including the risk and internal control design assessment services related to the implementation of the new system, limited assurance on certain sustainability information and agreed-upon procedures.\n\n*3Tax fees include fees for tax compliance assistance for a subsidiary in liquidation.\n\n*4Other fees include fees for other permissible services including readiness review for certain rule and regulations.\n\nPre‑Approval Policies and Procedures\n\nPursuant to Rule 2-01(c)(7)(i) of Regulation S-X, we have adopted policies and procedures under which all services (including permissible non-audit services) for which we or our subsidiaries engage our independent certified public accountant, KPMG AZSA LLC, and its affiliates must be approved by our Audit and Supervisory Committee prior to entering into an engagement.\n\nAll audit services are subject to the pre-approval by the Audit and Supervisory Committee in principle, regardless of monetary value. Audit services include statutory or financial statement audits for us and our subsidiaries, services associated with the audit of internal control over financial reporting and services associated with the review of our semi-annual financial statements. On a yearly basis, our management, following a review by our Chief Financial Officer, presents the proposed audit services to our Audit and Supervisory Committee for approval, and proposes audit fees on an entity basis to the Audit and Supervisory Committee for its consent. Once such services and fees are approved or consented to, as applicable, any additional audit services must be separately presented to and approved by our Audit and Supervisory Committee.\n\nPermissible non-audit services, which are limited to certain services permissible under applicable regulation and our internal rules, are pre-approved by the Audit and Supervisory Committee for individual services below JPY 25 million annually, subject to an aggregate annual limit of up to JPY 250 million for all such services. These services are subject to review by our management for compliance with our internal policies. All non-audit services exceeding the applicable monetary limits or which are not clearly within the scope of permitted non-audit services must be presented to and pre-approved by the Audit and Supervisory Committee. All services relating to tax or internal control are also subject to separate presentation to and pre-approval by the Audit and Supervisory Committee regardless of monetary value.\n\n140\n\n[Table of Contents](#i89761be648564855b53fa24df8e6ee90_10)"}